Lung Neoplasms: all 7,334 studies
Page 52 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRTCompletedNCT02456246Not applicable
- Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT02454842Phase 2
- Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung CancerWithdrawnNCT02451865Phase 1
- Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung CarcinomaCompletedNCT02449122Phase 1/2
- Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutationStatus unknownNCT02448797Phase 3
- Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung CancerTerminatedNCT02448251Phase 1
- Marker Guided Breathhold Radiotherapy in NSCLCCompletedNCT02447900Phase 1
- Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior ChemotherapyStatus unknownNCT02446704Phase 1/2
- Micro RNA Genetic Signature in NSCLC Egyptian PatientsCompletedNCT02445924
- Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin ChemotherapyStatus unknownNCT02445872Phase 2
- COPDGene/Lung Cancer Center DatabaseCompletedNCT02445183
- Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA)Status unknownNCT02439073Not applicable
- The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer MonitoringStatus unknownNCT02437760
- Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung MalignanciesActive, not recruitingNCT02434809Not applicable
- Alberta Lung Cancer Screening ProgramStatus unknownNCT02431962Not applicable
- Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease ProgressionTerminatedNCT02431169
- Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function InsufficiencyCompletedNCT02430753Not applicable
- Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis NeoplasmsCompletedNCT02430597Not applicable
- A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung CancerCompletedNCT02429843Phase 1
- Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung CarcinomaWithdrawnNCT02428764Phase 2
- Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)CompletedNCT02425748Phase 1/2
- NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung CancerWithdrawnNCT02425072Phase 2
- Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung CancersStatus unknownNCT02423590Phase 2
- Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung CancerWithdrawnNCT02423148Not applicable
- Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLCStatus unknownNCT02422628
- Mutation Detection of EBUS-TBNA Specimens Using NGSCompletedNCT02420405Not applicable
- Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
- Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT02419170Early Phase 1
- Anticancer Activity of Nicotinamide on Lung CancerStatus unknownNCT02416739Phase 2/3
- Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGSCompletedNCT02416726Not applicable
- Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?TerminatedNCT02416570Phase 2
- CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer PatientsCompletedNCT02414672Not applicable
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
- Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerCompletedNCT02410603
- Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung CancerStatus unknownNCT02410369Phase 2
- Perfusion-Induced Hyperthermia for Metastatic CarcinomaCompletedNCT02409108Not applicable
- Phase I Trial of VS-6766 Alone and in Combination With EverolimusCompletedNCT02407509Phase 1
- Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung CancerStatus unknownNCT02407366Phase 2
- Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.WithdrawnNCT02405910Phase 2
- Pulmonary Resection And Intensive RehabilitationCompletedNCT02405273Not applicable
- Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT02403193Phase 1
- MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung CancerTerminatedNCT02400814Phase 1
- Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorTerminatedNCT02400424Not applicable
- Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung CancerStatus unknownNCT02397239
- Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPLStatus unknownNCT02395939Phase 3
- Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung ResectionStatus unknownNCT02393664Phase 2/3
- A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With CancerCompletedNCT02391480Phase 1
- Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）CompletedNCT02388919Phase 2/3
- Screening of Alberta Asbestos Exposed Workers for Lung Cancer and MesotheliomaTerminatedNCT02385812Phase 2
- Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory CancerCompletedNCT02381314Phase 1
- The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung CancerCompletedNCT02380196
- DECT Ventilation ImagingTerminatedNCT02377518Not applicable
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR MutationsStatus unknownNCT02375022Phase 2
- A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLCCompletedNCT02374645Phase 1
- Characterization of Methylation Patterns in Lung CancerCompletedNCT02373917
- Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer PatientsCompletedNCT02372448Not applicable
- A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant MesotheliomaTerminatedNCT02372227Phase 1
- A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemCompletedNCT02370303
- MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLCCompletedNCT02369198Phase 1
- Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLCStatus unknownNCT02367443Phase 1/2
- A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung CancerCompletedNCT02364804
- A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02364362Phase 1
- Health Outcomes and Costs (HOC) in Lung Cancer (LC)Status unknownNCT02363101
- Lung Cancer Nurse Model: a Phase II StudyStatus unknownNCT02362204
- SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer RelapseCompletedNCT02361099Phase 3
- Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and LobectomyStatus unknownNCT02360761Phase 3
- Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS StudyCompletedNCT02359175Phase 4
- A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT02356991Phase 2
- Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLCTerminatedNCT02353741Phase 2
- Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.Status unknownNCT02350361Phase 2/3
- Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung CancerStatus unknownNCT02348450Phase 4
- NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.WithdrawnNCT02347839Phase 2
- The Randomized Controlled Clinical Trial of Kushen InjectionStatus unknownNCT02346318Phase 4
- Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and CaregiversCompletedNCT02345798Not applicable
- Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)TerminatedNCT02342353Phase 1
- A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47CompletedNCT02340208Phase 1/2
- Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)Status unknownNCT02338011Phase 2/3
- Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung CancerStatus unknownNCT02337712Phase 2
- Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung CancerTerminatedNCT02336061
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryCompletedNCT02334007Phase 1/2
- Safety and Efficacy of Mix Vaccine in Lung Carcinoma PatientCompletedNCT02333474Phase 1/2
- Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)Status unknownNCT02332512Phase 3
- Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy RegimenStatus unknownNCT02331290
- Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?CompletedNCT02331056
- Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLCStatus unknownNCT02330367Phase 1/2
- Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIBTerminatedNCT02326285Phase 2/3
- PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive CasesCompletedNCT02324296
- Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung CancerCompletedNCT02323737Phase 2
- A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLCStatus unknownNCT02321293Phase 1
- An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).CompletedNCT02321046
- Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung CancerStatus unknownNCT02320617Not applicable
- Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung CarcinomaTerminatedNCT02319889Early Phase 1
- GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA TrialStatus unknownNCT02319577Phase 2
- Immune Boost In Non-Small Cell Lung CancerCompletedNCT02319408Not applicable
- Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerCompletedNCT02318771Phase 1
- Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and BevacizumabCompletedNCT02316327Phase 4
- Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?CompletedNCT02309567
- Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerCompletedNCT02309177Phase 1
- Early Palliative Care in Metastatic Lung Cancer in Northern FranceTerminatedNCT02308865Not applicable